Retaglutide is a innovative GLP-1 receptor agonist currently under research for the treatment of type 2 diabetes. This drug works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://orlandoftab092067.elbloglibre.com/39159453/retaglutide-a-promising-glp-1-receptor-agonist